Anne Clark

9.9k total citations · 1 hit paper
120 papers, 7.5k citations indexed

About

Anne Clark is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Anne Clark has authored 120 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Surgery, 56 papers in Endocrinology, Diabetes and Metabolism and 53 papers in Genetics. Recurrent topics in Anne Clark's work include Pancreatic function and diabetes (87 papers), Diabetes and associated disorders (48 papers) and Diabetes Treatment and Management (26 papers). Anne Clark is often cited by papers focused on Pancreatic function and diabetes (87 papers), Diabetes and associated disorders (48 papers) and Diabetes Treatment and Management (26 papers). Anne Clark collaborates with scholars based in United Kingdom, United States and Netherlands. Anne Clark's co-authors include Garth J. S. Cooper, R. C. Turner, K.B.M. Reid, Robert B. Sim, Anthony C. Willis, Eelco J.P. de Koning, John F. Morris, Melanie R. Nilsson, Patrik Rorsman and Barbara C. Hansen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Anne Clark

120 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

1987 1.1k citations Anne Clark, R. C. Turner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Clark United Kingdom	46	4.3k	2.9k	2.6k	2.5k	2.1k	120	7.5k
C. Bruce Verchere Canada	50	4.0k 0.9×	2.6k 0.9×	2.1k 0.8×	2.1k 0.8×	2.2k 1.0×	163	7.7k
Juliette Janson Sweden	17	3.4k 0.8×	2.2k 0.8×	2.0k 0.8×	1.8k 0.7×	1.7k 0.8×	23	5.9k
Nils Welsh Sweden	44	4.2k 1.0×	2.9k 1.0×	2.1k 0.8×	1.2k 0.5×	2.5k 1.2×	165	7.4k
Jean‐Christophe Jonas Belgium	43	4.2k 1.0×	2.9k 1.0×	2.0k 0.8×	903 0.4×	1.9k 0.9×	98	6.6k
Erol Cerasi Israel	51	5.0k 1.2×	3.8k 1.3×	4.0k 1.6×	1.5k 0.6×	2.4k 1.1×	234	8.7k
Herbert Y. Gaisano Canada	54	4.2k 1.0×	4.0k 1.4×	1.6k 0.6×	1.1k 0.5×	1.3k 0.6×	228	8.1k
Marco Bugliani Italy	45	3.9k 0.9×	2.6k 0.9×	2.1k 0.8×	840 0.3×	1.9k 0.9×	92	6.5k
Tatyana Gurlo United States	32	2.4k 0.6×	2.0k 0.7×	1.3k 0.5×	1.7k 0.7×	1.1k 0.5×	60	4.9k
F Malaisse-Lagae Switzerland	48	5.7k 1.3×	3.4k 1.2×	3.5k 1.4×	1.2k 0.5×	2.5k 1.2×	226	7.6k
Yoshio Fujitani Japan	51	3.9k 0.9×	3.4k 1.2×	2.9k 1.1×	1.0k 0.4×	2.0k 0.9×	169	9.6k

Countries citing papers authored by Anne Clark

Since Specialization

Citations

This map shows the geographic impact of Anne Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Clark more than expected).

Fields of papers citing papers by Anne Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Clark. The network helps show where Anne Clark may publish in the future.

Co-authorship network of co-authors of Anne Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Clark. A scholar is included among the top collaborators of Anne Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Clark. Anne Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramracheya, Reshma, Caroline Chapman, Margarita V. Chibalina, et al.. (2018). GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca ²⁺ channels. Physiological Reports. 6(17). e13852–e13852. 81 indexed citations

Thomsen, Soren K., Anne Raimondo, Benoît Hastoy, et al.. (2018). Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells. Nature Genetics. 50(8). 1122–1131. 45 indexed citations

Hastoy, Benoît, Anne Clark, Vibe Nylander, et al.. (2018). Electrophysiological properties of human beta-cell lines EndoC-βH1 and -βH2 conform with human beta-cells. Scientific Reports. 8(1). 16994–16994. 26 indexed citations

Ramracheya, Reshma, Laura McCulloch, Anne Clark, et al.. (2016). PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery. Cell Reports. 15(5). 944–950. 72 indexed citations

Ramracheya, Reshma, Fernando Abdulkader, Makoto Shigeto, et al.. (2010). GLP-1 inhibits glucagon secretion from human alpha cells by a direct effect. Diabetologia. 53. 1 indexed citations

Braun, Matthias, Reshma Ramracheya, Martin Bengtsson, et al.. (2010). γ-Aminobutyric Acid (GABA) Is an Autocrine Excitatory Transmitter in Human Pancreatic β-Cells. Diabetes. 59(7). 1694–1701. 185 indexed citations

Flamez, Daisy, I. Roland, Alix Berton, et al.. (2010). A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)γa as a pancreatic beta cell-specific biomarker. Diabetologia. 53(7). 1372–1383. 33 indexed citations

Cnop, Miriam, Stephen J. Hughes, Mariana Igoillo‐Esteve, et al.. (2009). The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia. 53(2). 321–330. 182 indexed citations

Girard, Christophe A., F. Thomas Wunderlich, Kenju Shimomura, et al.. (2008). Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic β cells recapitulates neonatal diabetes. Journal of Clinical Investigation. 119(1). 80–90. 89 indexed citations

10.

Braun, Matthias, Anna Wendt, Jovita Karanauskaite, et al.. (2007). Corelease and Differential Exit via the Fusion Pore of GABA, Serotonin, and ATP from LDCV in Rat Pancreatic β Cells. The Journal of General Physiology. 129(3). 221–231. 88 indexed citations

11.

Wabitsch, Martin, Georgia Lahr, Martijn van de Bunt, et al.. (2007). Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy. Diabetic Medicine. 24(12). 1393–1399. 53 indexed citations

12.

Esapa, Christopher T., Anna Novials, Catherine McNamara, et al.. (2005). Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1740(1). 74–78. 12 indexed citations

13.

Fielding, Barbara A., et al.. (2005). Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia. 48(9). 1819–1829. 97 indexed citations

14.

Barrow, B., et al.. (2000). Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance. Diabetes Research and Clinical Practice. 50(2). 117–126. 9 indexed citations

15.

Badman, Michael K., et al.. (1996). Processing of pro‐islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Letters. 378(3). 227–231. 49 indexed citations

16.

Chargé, Sophie, Eelco J.P. de Koning, & Anne Clark. (1995). Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochemistry. 34(44). 14588–14593. 79 indexed citations

17.

Höppener, Jo W.M., H.S. Jansz, Cor Oosterwijk, et al.. (1994). Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice. Journal of Cellular Biochemistry. 55(S1994A). 39–53. 35 indexed citations

18.

Turner, R. C., J Lévy, & Anne Clark. (1993). Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms.. PubMed. 86(7). 413–7. 24 indexed citations

19.

Clark, Anne, et al.. (1991). Autoantibodies to Islet Amyloid Polypeptide in Diabetes. Diabetic Medicine. 8(7). 668–673. 15 indexed citations

20.

Clark, Anne, et al.. (1990). Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia. 33(5). 285–289. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact